In vitro differentiation of embryonic stem cells: Immunophenotypic analysis of cultured embryoid bodies

Abstract

The process of in vitro embryonic stem cell differentiation and embryoid body development was monitored using a panel of antibodies against surface markers traditionally associated with embryonic tissue (Forssman, SSEA‐1) and hematopoietic progenitor cells (Fall‐3, HSA, Sca‐1, Thy‐1.2, ER‐MP12, CD45, AA4.1, and c‐kit). All markers with the exception of CD45 and AA4.1 were initially detected in cultures of undifferentiated ES cells. During the first 11 days of differentiation, distinct and reproducible patterns of surface expression were observed for each marker. Using the kinetic display of surface markers as a gauge of differentiation, perturbations in embryoid body development were detected in cultures supplemented with interleukin‐11, a gp130‐activating cytokine thought to affect embryonic stem cell differentiation. In the absence of exogenous cytokines, microbead immunoselected day 7 c‐kit, ER‐MP12, and CD45‐positive embryoid body cells were enriched for hematopoietic progenitors as detected by methylcellulose colony assays, while no significant enrichment of hematopoietic progenitors was observed with Sca‐1, Thy‐1.2, Fall‐3, and Forssman‐immunoselected cells. These results indicate that the process of early embryoid body development is associated with a programmed sequence of cell surface marker display, concomitant with the development of phenotypically definable embryonic cell lineages. J. Cell. Physiol. 171:104–115, 1997.